Replies to post #269823 on Innovation Pharmaceuticals Inc (IPIX)

[MinnieM]

http://www.ipharminc.com/press-release/2017/12/27/innovation-pharmaceuticals-obtains-direct-evidence-of-molecular-pathways-modulation-in-tumors-from-first-patients-in-kevetrin-ph2a-ovarian-cancer-trial?rq=modulate%20p53

Modulation of the p53 protein was observed in response to administration of Kevetrin.

In Reply to 'kfcyahoo'
Perhaps I missed it. What additional detail (more specific detail) has ipix provided beyond the HemaSphere journal review?